Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07463092
Eligibility Criteria:
Inclusion Criteria:
* Men aged ≥ 40 years;
* Patients with histologically or cytologically confirmed localized prostate cancer;
* Patients who have undergone surgical castration or pharmacological castration with gonadotropin-releasing hormone (GnRH/LHRH) agonists or antagonists for at least six months prior to the start of the intervention;
* Patients receiving continuous or intermittent androgen deprivation therapy;
* Patients with an Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2;
* Not engaged in resistance training in the three months prior to the intervention;
* Not using creatine supplementation in the three months prior to the intervention;
* Willing to participate in a 12-week intervention consisting of resistance training performed three times per week and daily supplementation with creatine monohydrate or maltodextrin.
Exclusion Criteria:
* Patients with insulin-dependent diabetes mellitus;
* Patients with dialysis-dependent renal failure;
* Patients with severe chronic liver disease;
* Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m²;
* Any hormonal treatment outside that established by the medical team;
* Patients planning to undergo chemotherapy within the next six months.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
40 Years
Study:
NCT07463092
Study Brief:
Protocol Section:
NCT07463092